Hillsdale Investment Management Inc. Catalent, Inc. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$39.4 - $47.39 $1.34 Million - $1.62 Million	-34,100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$37.27 - $43.02 $111,810 - $129,060	3,000 Added 9.65%	34,100 $1.4 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $168,750 - $208,350	5,000 Added 19.16%	31,100 $1.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	26,100	26,100 $916,000

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.8B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.